STOCK TITAN

[144] ADMA BIOLOGICS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Fidelity Brokerage Services submitted a Form 144 reporting planned sales of Common Stock tied to option exercises and restricted stock unit vesting. The notice lists proposed sales of 60,000 and 125,000 shares from option exercises and 13,014 and 10,986 shares from RSU vesting.

The filing also records recent dispositions of 21,000 shares on 12/15/2025 for $415,590 and 21,000 shares on 11/19/2025 for $336,000.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 notice showing planned insider-related sales and recent dispositions.

The filing lists proposed sales of 60,000 and 125,000 shares tied to option exercises and 13,014 and 10,986 shares from RSU vesting. These entries are transactional notices under Rule 144 rather than new issuance.

Cash-flow treatment for the planned sales is not detailed beyond the listed exercise/compensatory types; recent disclosed dispositions include 21,000 shares on 12/15/2025 and 21,000 shares on 11/19/2025, with proceeds shown.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Adma Biologics

NASDAQ:ADMA

ADMA Rankings

ADMA Latest News

ADMA Latest SEC Filings

ADMA Stock Data

3.81B
228.20M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
RAMSEY